STAT3 and Alzheimer disease: In this study, we found that LILRB4 silencing suppresses AD development by promoting contractile phenotype switch of HASMCs, enhancing ECM stability, and inhibiting pyroptosis, potentially by regulating the JAK2/STAT3 signaling pathway.